Houston biotech cos. begin clinical trials for cancer, Covid-19 treatments

Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.

Houston biotech cos. begin clinical trials for cancer, Covid-19 treatments

Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.